Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis
- PMID: 22726388
- PMCID: PMC3441502
- DOI: 10.1186/1471-230X-12-76
Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis
Abstract
Background: Accurate diagnostic and monitoring tools for ulcerative colitis (UC) are missing. Our aim was to describe the proteomic profile of UC and search for markers associated with disease exacerbation. Therefore, we aimed to characterize specific proteins associated with inflamed colon mucosa from patients with acute UC using mass spectrometry-based proteomic analysis.
Methods: Biopsies were sampled from rectum, sigmoid colon and left colonic flexure from twenty patients with active proctosigmoiditis and from four healthy controls for proteomics and histology. Proteomic profiles of whole colonic biopsies were characterized using 2D-gel electrophoresis, and peptide mass fingerprinting using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was applied for identification of differently expressed protein spots.
Results: A total of 597 spots were annotated by image analysis and 222 of these had a statistically different protein level between inflamed and non-inflamed tissue in the patient group. Principal component analysis clearly grouped non-inflamed samples separately from the inflamed samples indicating that the proteomic signature of colon mucosa with acute UC is strong. Totally, 43 individual protein spots were identified, including proteins involved in energy metabolism (triosephosphate isomerase, glycerol-3-phosphate-dehydrogenase, alpha enolase and L-lactate dehydrogenase B-chain) and in oxidative stress (superoxide dismutase, thioredoxins and selenium binding protein).
Conclusions: A distinct proteomic profile of inflamed tissue in UC patients was found. Specific proteins involved in energy metabolism and oxidative stress were identified as potential candidate markers for UC.
Figures



Similar articles
-
MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.World J Gastroenterol. 2017 Aug 7;23(29):5324-5332. doi: 10.3748/wjg.v23.i29.5324. World J Gastroenterol. 2017. PMID: 28839432 Free PMC article.
-
Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.Inflamm Bowel Dis. 2011 Apr;17(4):875-83. doi: 10.1002/ibd.21442. Epub 2010 Aug 30. Inflamm Bowel Dis. 2011. PMID: 20806340 Free PMC article.
-
Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.Gut. 2019 Dec;68(12):2142-2151. doi: 10.1136/gutjnl-2018-317571. Epub 2019 Mar 26. Gut. 2019. PMID: 30914450 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
A comprehensive review and update on ulcerative colitis.Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. Dis Mon. 2019. PMID: 30837080 Review.
Cited by
-
Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review.Diagnostics (Basel). 2020 Aug 17;10(8):601. doi: 10.3390/diagnostics10080601. Diagnostics (Basel). 2020. PMID: 32824619 Free PMC article. Review.
-
Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.Exp Ther Med. 2018 May;15(5):4477-4484. doi: 10.3892/etm.2018.5946. Epub 2018 Mar 9. Exp Ther Med. 2018. PMID: 29731832 Free PMC article.
-
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares.Ann Rheum Dis. 2023 Oct;82(10):1315-1327. doi: 10.1136/ard-2023-223929. Epub 2023 Jun 26. Ann Rheum Dis. 2023. PMID: 37365013 Free PMC article.
-
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.World J Gastroenterol. 2015 Jan 7;21(1):21-46. doi: 10.3748/wjg.v21.i1.21. World J Gastroenterol. 2015. PMID: 25574078 Free PMC article. Review.
-
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.World J Gastroenterol. 2014 Mar 28;20(12):3231-44. doi: 10.3748/wjg.v20.i12.3231. World J Gastroenterol. 2014. PMID: 24696607 Free PMC article. Review.
References
-
- Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002. Eur J Gastroenterol Hepatol. 2006;18:601–606. doi: 10.1097/00042737-200606000-00005. - DOI - PubMed
-
- Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RSN, Floyd JAB, Florin T, Franchimont D. et al.Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246–252. doi: 10.1038/ng.764. - DOI - PMC - PubMed
-
- Andersen V, Nimmo E, Krarup HB, Drummond H, Christensen J, Ho GT, Ostergaard M, Ernst A, Lees C, Jacobsen BA, Satsangi J, Vogel U. Cyclooxygenase-2 (COX-2) Polymorphisms and Risk of Inflammatory Bowel Disease in a Scottish and Danish Case–control Study. Inflamm Bowel Dis. 2011;17:937–946. doi: 10.1002/ibd.21440. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical